agilon health Corrects Post-Split Share Count in Reverse Stock Split Proxy

summarizeSummary

agilon health, inc. filed a supplement to its definitive proxy statement, correcting an administrative error regarding the potential number of outstanding shares following the proposed reverse stock split.

check_boxKey Events · Corporate Governance and Compliance · AGL

• Corrects Post-Split Share Count

  The company corrected an administrative error in its definitive proxy statement, revising the potential number of outstanding shares after the proposed reverse stock split from approximately 20.7 million to 16.6 million shares.

• Supplements Previous Proxy Filing

  This filing serves as a supplement to the definitive proxy statement filed on February 18, 2026, providing clarification without altering the underlying reverse stock split proposal or the Board's recommendation.

• Special Meeting on March 17, 2026

  Stockholders are scheduled to vote on the reverse stock split proposal at a special meeting on March 17, 2026, as previously disclosed.

auto_awesomeAnalysis · AGL · Industrial Applications And Services

This DEFA14A filing provides a material correction to the definitive proxy statement filed on February 18, 2026, which detailed a proposed reverse stock split. The company adjusted the potential post-split outstanding share count from approximately 20.7 million to 16.6 million shares due to an administrative error. While the core proposal for a reverse stock split and the Board's recommendation remain unchanged, this update provides more accurate information regarding the potential capital structure post-split. Investors should note this clarification as they consider the upcoming vote on the reverse stock split, which is generally viewed as a measure to address low share price and maintain listing compliance.